Cholangiocarcinoma: Diagnosis and Management

Area of Science:

• Hepatobiliary Medicine
• Oncology
• Gastroenterology

Background:

• Cholangiocarcinoma is a rare, lethal biliary epithelial malignancy.
• It occurs at increased rates in patients with primary sclerosing cholangitis (PSC).
• Management is complex due to tumor heterogeneity and location.

Purpose of the Study:

• To review the epidemiology, presentation, diagnosis, and management of cholangiocarcinoma.
• To highlight the increased risk and screening considerations in PSC patients.
• To discuss current and potential therapeutic strategies.

Main Methods:

• Review of current medical literature on cholangiocarcinoma.
• Analysis of diagnostic modalities including imaging and laboratory tests.
• Evaluation of treatment outcomes for resectable and unresectable disease.

Main Results:

• Cholangiocarcinoma often presents at advanced stages with jaundice and weight loss.
• Diagnosis involves advanced imaging (MRCP), lab tests, and ERCP.
• Resection and liver transplant offer curative potential, while other therapies provide survival benefits for unresectable cases.

Conclusions:

• Effective prevention strategies for cholangiocarcinoma are lacking.
• Screening may be feasible primarily in the PSC population.
• Multimodal treatment approaches are essential for managing this challenging cancer.